Clinical trials
Withdrawn Hyperparathyroidism, Secondary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2013 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| OPKO Health, Inc. | 1 |
| Theraclion | 1 |
| University of Sao Paulo General Hospital | 1 |
| University of Virginia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 4 |
| Kidney Failure, Chronic | 2 |
| Renal Insufficiency, Chronic | 2 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
| Hyperparathyroidism | 1 |
| Inflammation | 1 |
| Proteinuria | 1 |
| Restless Legs Syndrome | 1 |
| Vitamin D Deficiency | 1 |
Trials
Showing 51 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.